ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
118.84
-5.39 (-4.34%)
At close: Jul 29, 2026, 4:00 PM EDT
119.82
+0.98 (0.82%)
After-hours: Jul 29, 2026, 7:54 PM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $10.63 billion as of July 29, 2026. Its market cap has increased by 111.51% in one year.
Market Cap
10.63B
Enterprise Value
10.11B
1-Year Change
111.51%
Ranking
Category
Stock Price
$118.84
ChartMarket Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $10.63B, an increase of 4,616.40%. That is a compound annual growth rate of 41.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 10.69B | -2.87% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 12.55B |
| Axsome Therapeutics | 12.40B |
| Arrowhead Pharmaceuticals | 12.06B |
| BioMarin Pharmaceutical | 11.47B |
| Bio-Techne | 11.16B |
| Cytokinetics | 10.96B |
| Summit Therapeutics | 10.90B |
| Corcept Therapeutics | 10.24B |